Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Oxytocin and Atosiban

supplement:

Oxytocin

Research Papers that Mention the Interaction

CONCLUSION A 2-hour infusion of the ox tocin an tagonist ato siban re sulted in a significantly greater decline in contraction frequency compared with controls.
American journal of obstetrics and gynecology  •  1994  |  View Paper
Positive effects of oxytocin on insulin secretion were almost fully annulled by the oxytocin receptor antagonist, atosiban.
Peptides  •  2018  |  View Paper
We have demonstrated that atosiban and nolasiban not only inhibit contractions elicited by OT , but also inhibit contractions and inflammation induced by PGF2α.
Scientific Reports  •  2019  |  View Paper
Critically, intranasal oxytocin administration restores the temporal compression effect in socially less proficient individuals, whereas the administration of atosiban , a competitive antagonist of oxytocin , diminishes the effect in socially proficient individuals.
eLife  •  2018  |  View Paper
In the control group Atosiban re-established NO levels that were reduced after incubation with oxytocin , while in preterm samples NO levels were not only re-established but, after incubation with Atosiban, significantly increased compared to basal levels.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians  •  2015  |  View Paper
Co-treatment with oxytocin and oxytocin receptor antagonist— atosiban —resulted in significant increase of MAP2 gene expression in SK-N-SH cells.
Surprisingly, oxytocin with atosiban significantly increased mRNA levels for both BDNF and NGF.
Journal of Molecular Neuroscience  •  2013  |  View Paper
Atosiban , a newer drug, is a competitive antagonist of oxytocin and has been claimed to have fewer cardiovascular side effects.
European Journal of Clinical Pharmacology  •  2011  |  View Paper
Atosiban , a newer tocolytic drug, is a competitive antagonist of oxytocin and has fewer cardiovascular side effects.
European Journal of Clinical Pharmacology  •  2010  |  View Paper
Atosiban acts through selective, competitive inhibition of both oxytocin and vasopressin, so that there are reasons to assume that a tocolytic effect can also be achieved earlier in the pregnancy.
Archives of Gynecology and Obstetrics  •  2004  |  View Paper
Show More